P2Y12 inhibitors are a class of antiplatelet drugs commonly used to prevent blood clots in conditions like acute coronary syndrome, stroke, or after stent placement. Here’s a list of widely recognized P2Y12 inhibitors:

1. Clopidogrel (Brand name: Plavix)
   • One of the most commonly used P2Y12 inhibitors, often prescribed after heart attacks or stent procedures.
2. Prasugrel (Brand name: Effient)
   • More potent than clopidogrel, typically used in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI).
3. Ticagrelor (Brand name: Brilinta)
   • A reversible P2Y12 inhibitor, often used in acute coronary syndrome, with a faster onset and offset of action compared to clopidogrel.
4. Cangrelor (Brand name: Kengreal)
   • An intravenous P2Y12 inhibitor used during PCI when oral medications cannot be administered. It has a very short half-life.
5. Ticlopidine (Brand name: Ticlid)
   • An older P2Y12 inhibitor, less commonly used today due to side effects like neutropenia, but still available in some regions.

These medications work by inhibiting the P2Y12 receptor on platelets, preventing ADP-mediated platelet aggregation. The choice of drug depends on factors like patient condition, risk of bleeding, and response to therapy. Always consult a healthcare provider for specific medical advice or prescriptions.

Disclaimer: NOT MEDICAL ADVICE